Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines
V Cottin, B Crestani, D Valeyre… - European …, 2014 - Eur Respiratory Soc
Idiopathic pulmonary fibrosis (IPF) is the most frequent chronic idiopathic interstitial
pneumonia in adults. The management of rare diseases in France has been organised by a …
pneumonia in adults. The management of rare diseases in France has been organised by a …
Combined pulmonary fibrosis and emphysema: a retrospective analysis of clinical characteristics, treatment and prognosis
L Zhang, C Zhang, F Dong, Q Song, F Chi, L Liu… - BMC Pulmonary …, 2016 - Springer
Background Combined pulmonary fibrosis and emphysema (CPFE) is increasingly
acknowledged as a separate syndrome with distinct clinical, physiological and radiological …
acknowledged as a separate syndrome with distinct clinical, physiological and radiological …
Anesthesia and pulmonary hypertension
D McGlothlin, N Ivascu, PM Heerdt - Progress in cardiovascular diseases, 2012 - Elsevier
Anesthesia and surgery are associated with significantly increased morbidity and mortality in
patients with pulmonary hypertension due mainly to right ventricular failure, arrhythmias …
patients with pulmonary hypertension due mainly to right ventricular failure, arrhythmias …
Pulmonary hypertension in interstitial lung disease and in chronic obstructive pulmonary disease: different entities?
L Piccari, R Aguilar-Colindres… - Current Opinion in …, 2023 - journals.lww.com
The development of PH in lung disease significantly worsens the morbidity and mortality of
patients with COPD and ILD. However, recent findings show importance of recognizing …
patients with COPD and ILD. However, recent findings show importance of recognizing …
Connective tissue diseases, multimorbidity and the ageing lung
P Spagnolo, JF Cordier, V Cottin - European Respiratory …, 2016 - Eur Respiratory Soc
Connective tissue diseases encompass a wide range of heterogeneous disorders
characterised by immune-mediated chronic inflammation often leading to tissue damage …
characterised by immune-mediated chronic inflammation often leading to tissue damage …
Erratum: 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of …
M Humbert, G Kovacs, MM Hoeper… - … : 2022 ESC/ERS …, 2023 - produccioncientifica.ucm.es
Erratum: 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension:
Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the …
Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the …
Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease
Background Pulmonary hypertension (PH) complicating systemic sclerosis (SSc)-related
interstitial lung disease (ILD) is usually associated with a poor prognosis. However, data are …
interstitial lung disease (ILD) is usually associated with a poor prognosis. However, data are …
Clinical profile of patients with idiopathic pulmonary fibrosis in real life
D Morena, J Fernández, C Campos, M Castillo… - Journal of Clinical …, 2023 - mdpi.com
Objective: The objective of this study is to define the real-life clinical profile and therapeutic
management of patients with idiopathic pulmonary fibrosis using artificial intelligence …
management of patients with idiopathic pulmonary fibrosis using artificial intelligence …
Pulmonary hypertension due to lung diseases: Updated recommendations from the Cologne Consensus Conference 2018
H Olschewski, J Behr, H Bremer, M Claussen… - International journal of …, 2018 - Elsevier
Abstract The 2015 European Guidelines on Pulmonary Hypertension did not only cover
pulmonary arterial hypertension (PAH) but also some aspects of pulmonary hypertension …
pulmonary arterial hypertension (PAH) but also some aspects of pulmonary hypertension …
Comorbid conditions in chronic obstructive pulmonary disease: Potential therapeutic targets for unmet needs
K Matsunaga, M Harada, J Suizu, K Oishi… - Journal of clinical …, 2020 - mdpi.com
The management of chronic obstructive pulmonary disease (COPD) has improved
significantly due to advances in therapeutic agents, but it has also become apparent that …
significantly due to advances in therapeutic agents, but it has also become apparent that …